Drug Type Small molecule drug |
Synonyms Anhydrous sodium sulfate, Natrii Sulfus, Natrium Sulfuricum + [10] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaH2Na2O4S |
InChIKeyHJCUCLCJVVFBTD-UHFFFAOYSA-N |
CAS Registry7757-82-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
ST Elevation Myocardial Infarction | Phase 2 | - | 01 Dec 2009 | |
Coronary Artery Disease | Phase 2 | Australia | 01 May 2009 | |
Coronary Artery Disease | Phase 2 | Canada | 01 May 2009 | |
Oxygen radical damage | Phase 2 | Australia | 01 May 2009 | |
Oxygen radical damage | Phase 2 | Canada | 01 May 2009 | |
Myocardial Infarction | Phase 2 | - | - | |
Myocardial Ischemia | Phase 2 | Australia | - | |
Myocardial Ischemia | Phase 2 | Canada | - | |
Reperfusion Injury | Phase 2 | Australia | - | |
Reperfusion Injury | Phase 2 | Canada | - |
Not Applicable | - | 595 | Sodium sulfate, magnesium sulfate, potassium chloride tablet | rredtojrro(visrwkkhwy) = ocjkgdmxdi zoxsttlbrf (agjhiruyvw ) View more | Positive | 20 May 2024 | |
Sodium, magnesium, potassium sulfate solution | rredtojrro(visrwkkhwy) = jibcplffnb zoxsttlbrf (agjhiruyvw ) View more | ||||||
Not Applicable | 381 | (Intensive Glucose Control, Dexamethasone, Light Anesthesia) | yuxeewonne = qegsmnrccm odyaznebtw (ncpakzmwjm, uztjmoanxe - poxtvfnwip) View more | - | 25 Apr 2017 | ||
Anesthesia management -Placebo+Dexamethasone Sodium Sulfate (Intensive Glucose Control, Dexamethasone, Deep Anesthesia) | yuxeewonne = eypknbpoio odyaznebtw (ncpakzmwjm, gjkspjcbyy - wpoipddnmm) View more | ||||||
Phase 1 | 28 | (Sodium Sulfide - Mild Cohort) | skxwaxzgnx(ariofpgnnt) = hvpsfgjtgg bbkbjhywiw (nhcbhhtght, 57.83) View more | - | 04 Nov 2010 | ||
(Sodium Sulfide - Healthy Cohort) | skxwaxzgnx(ariofpgnnt) = jboprnpnjl bbkbjhywiw (nhcbhhtght, 100.74) View more |